India's Wanbury drops after US drug regulator flags six observations at Andhra facility
21/07/2026 07:07
BUZZ-India's Wanbury drops after US drug regulator flags six observations at Andhra facility ** Pharma company Wanbury's shares WANB.NS fall as much as 7.61%, their steepest intraday drop in six weeks, to 314.05 rupees; last down 3.3%
** U.S. drug regulator issued form 483 with six observations after routine good manufacturing practices inspection at WANB's Andhra Pradesh facility
** Form 483 flags conditions that may violate U.S. FDA standards; multiple observations can raise concerns over potential remediation costs, delays in approvals or escalation to stricter regulatory action if not resolved
** WANB says it will respond to these observations within the stipulated time
** YTD, WANB up about 45%
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))
Recent news on Wanbury
See all newsBrief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility